Videos
The Urgent Need for Diversity and Inclusion in Myeloma Clinical Trials: The Maui Declaration
Dr. Joseph Mikhael, Chief Medical Officer at the International Myeloma Foundation (IMF), discusses the critical issue of diversity and inclusion in myeloma clinical trials.
Key points covered in…
News Article
International Myeloma Foundation to Hold First Latin American Myeloma Network Summit in Brazil on September 28
The inaugural IMF Latin American Myeloma Network Summit will take place on Saturday, September 28, after the International Myeloma Society (IMS) Meeting in Rio De Janeiro, Brazil.…
News Article
NLB Symposium at the 2024 ONS Congress
Nurse leaders educate peers about new therapies and regimens for patients with myeloma
By Diane Moran, Senior Vice President, Strategic Planning
On April 25, the IMF Nurse Leadership Board (NLB)…
Videos
Q&A: Myeloma Insights with Nurse Leadership Experts
Replay the Q&A with Beth Faiman, Tiffany Richards, and Donna Catamero from the International Myeloma Foundation's Nurse Leadership Board for a special live Q&A session during Blood Cancer Awareness Month.
They discuss…
News Article
At the end of every month, the International Myeloma Foundation Newsroom will feature a wrap-up of some of the most fascinating studies about multiple myeloma from medical journals. Here is the September 2024 edition.
The IMF team of medical editors has provided overviews of key studies. Yet, we…
Page
Where can I find clinical trials near me?
Welcome to your personalized clinical trial report. You can use the links below to discover and explore eligible clinical trials and myeloma centers from around the US. Powered by SparkCures.
What information do you need to show me clinical…
News Article
According to a September 20, 2024, press release, the U.S. Food and Drug Administration (FDA) has "approved isatuximab-irfc (Sarclisa, Sanofi-Aventis U.S. LLC) with bortezomib, lenalidomide, and dexamethasone for adults with newly diagnosed multiple myeloma who are not eligible for…
News Article
International Myeloma Foundation Launches Myelo: The First AI-Powered Responsive Chatbot to Provide Compassionate Myeloma Support for Patients, Care Partners, and Healthcare Professionals
Partners with ZS Associates and AWS to Develop Groundbreaking First-of-its-kind Gen AI Companion…
Videos
Impact of Relapses, Stem Cell Transplants, Diet and Nutrition: Answering Your Myeloma Questions
Dr. Joseph Mikhael, Chief Medical Officer of the International Myeloma Foundation, answers your top questions about multiple myeloma in this informative Q&A session.
From…
News Article
Coordination of Care in Myeloma
Myeloma Today in conversation with Beth Faiman and Charise Gleason
Beth and Charise, you deliver care to patients at two large institutions with specialized myeloma programs and a team approach to patient care. Please…
Audio
A Day in the Life of Lee and Shelley May with Insights from Dr. Elaine Wheat Dawson
In this episode, myeloma patient Lee May and his partner Shelley share how they navigate life with multiple myeloma.
Lee shares his story of diagnosis, treatment, and how they cope with the…
News Article
In this September 13, 2024, article from Fox News, Patti Scialfa's (Bruce Springsteen's wife and E Street bandmate) multiple myeloma diagnosis is discussed, and IMF Chief Medical Officer Dr. Joseph Mikhael explains aspects of the disease to readers. Visit the button below to read the full article…
News Article
In their September 11, 2024 issue, U.S. News & World Report published "A Guide to Multiple Myeloma: Symptoms, Treatment and Prognosis." The International Myeloma Foundation's (IMF) Chief Medical Officer Dr. Joseph Mikhael served as one of the experts who helped develop this content. …
Videos
What is Immunotherapy for Multiple Myeloma? Understanding Its Role in Treatment
What is immunotherapy, and how is it used to treat patients with multiple myeloma? In this video, Dr. Joseph Mikhael, Chief Medical Officer of the International Myeloma Foundation, answers the internet’s most…
News Article
2024 IMWG Summit Awards Honor Dr. Shaji Kumar and Dr. Francesca Gay
The International Myeloma Foundation (IMF) and the International Myeloma Working Group (IMWG) are proud to announce the 2024 recipients of the Robert A. Kyle Lifetime Achievement Award and the Brian G.M. Durie…
News Article
NBC News reports on Patti Scialfa's, Bruce Springsteen's wife and bandmate, multiple myeloma diagnosis, and the International Myeloma Foundation's Chief Medical Officer Joseph Mikhael sounds in on living well with the disease. Read the full article from NBC News from the button below.…
IMF Person
Lisette joined the IMF mid-2024, bringing with her a strong background in administrative work. Lisette lives in Nevada with her husband, 3 amazing kids and a dog. She enjoys spending time with her family. Lisette is honored to be part of a team that supports an important mission such as the IMF’s.
Q&A with Dr. Urvi A. Shah: Diet and Nutrition Tips for Myeloma, Fasting, & Probiotics | #kNowMyeloma
Videos
Q&A with Dr. Urvi A. Shah: Diet and Nutrition Tips for Myeloma, Fasting, & Probiotics
Watch the Blood Cancer Awareness Month Facebook Live replay with nutrition expert Dr. Urvi A. Shah
Replay Dr. Urvi A. Shah (Memorial Sloan Kettering Cancer Center) Q&A on diet and…
Videos
FDA Approved New 4-Drug Combo for Newly Diagnosed Myeloma Patients
Important Info You Need to Know!
Exciting news for newly diagnosed multiple myeloma patients! The US FDA has approved a powerful 4-drug combination therapy for frontline…
News Article
Historic Turning Point in Myeloma
ODAC unanimously votes in favor of MRD testing
On April 12, 2024, the U.S. Food and Drug Administration (FDA) held the Oncologic Drugs Advisory Committee (ODAC) meeting to evaluate available data to support the use of minimal residual disease…
News Article
At the end of every month, the International Myeloma Foundation Newsroom will feature a wrap-up of some of the most fascinating studies about multiple myeloma from medical journals. Here is the August 2024 edition.
The IMF team of medical editors has provided overviews of key studies. Yet, we…
News Article
Portland's "The Manual" features the article "Adventure for a cure: Myeloma survivors fighting back and advancing the cause," which discusses the International Myeloma Foundation's inaugural Iceland Cycling Expedition. It focuses…
News Article
Fox 26 (WTIV - Houston, TX) features IMF President and CEO Yelak Biru, as he prepares to leave for the International Myeloma Foundation's inaugural Iceland Cycling Expedition. The 3-day bike expedition includes patients, doctors,…
News Article
Watch the video and read the article from ABC 11 (WTVD in Durham, NC) about two cyclists who are taking part in the International Myeloma Foundation's inaugural Iceland Cycling Expedition, beginning August 29, 2024. These cyclists…
News Article
Read this article and watch a video with the International Myeloma Foundation's Chief Medical Officer Dr. Joseph Mikhael, as he explains the goals of the organization's inaugural Iceland Cycling Expedition. This event aims to raise…
News Article
The International Myeloma Foundation (IMF) Brings Back ‘Do You #kNOwMyeloma?’ for Blood Cancer Awareness Month 2024
LOS ANGELES, AUGUST 29, 2024 – With Blood Cancer Awareness Month coming up this September, the International Myeloma Foundation (IMF) is reviving…
News Article
The Brian D. Novis Grants Reception and Dinner took place on Saturday, August 17, at the Sheraton Universal Los Angeles in North Hollywood.
At the culmination of the Patient and Family Seminar (PFS) in Los Angeles, the IMF held its annual Brian D. Novis (BDN) Research Grant 2024…
Page
The IMF has created the Latin American Myeloma Network (LAMN) to conduct multinational trials, provide myeloma education to patients and providers, facilitate collaborative research, and deepen the myeloma expertise across the region of Latin America. It also serves to bring Latin American…
Event
On August 27th I will begin the 490-mile hike on the Camino de Santiago (the French Way) from Saint Jean Pied de Port in France to the Cathedral of Santiago de Compostela, Spain and will be raising donations for the International Myeloma Foundation. I anticipate the "Walk" will take 30 days. Over…
Page
Pedaling Through Iceland for a CauseThe 2026 Iceland Cycling Expedition Takes Place August 18–24, 2026A group of dedicated cyclists will embark on a unique adventure across the breathtaking landscapes of Iceland. Their mission: to raise critical funds for the International Myeloma Foundation's (IMF…
Page
Say Hello to MyeloYour 24/7 AI Assistant for Myeloma Support!Ever have a question about myeloma pop up at 3 am, leaving you frustrated and searching for answers? Now you can get the answers you need, anytime. Say hello to Myelo®, your 24/7 generative-AI assistant, specifically designed to support…
Videos
The International Myeloma Foundation Held a Patient and Family Seminar at the Hilton Los Angeles/Universal City from August 16-17, 2024.
IMF Patient and Family Seminars gather highly esteemed global myeloma researchers and healthcare professionals under one roof to share the latest developments…
News Article
NEW YORK CITY, August 15, 2024—The International Myeloma Foundation (IMF), in partnership with the National Medical Association (NMA), the W. Montague Cobb Institute, and the Student National Medical Association (SNMA), sent a delegation of twelve IMF Medical Student Scholars for…
News Article
According to an August 8, 2024, Sanofi press release, "Sarclisa induction treatment demonstrated significantly improved progression-free survival in patients with newly diagnosed multiple myeloma eligible for transplant." This conclusion was based on new results from "the two-part, double-…
Videos
Dr. Joseph Mikhael provides a rapid overview of groundbreaking research in multiple myeloma, highlighted from ASCO and EHA conferences. Key studies focus on newly diagnosed and early relapsed patients, CAR T-cell therapies, bispecific antibodies, and immunotherapy sequencing. Key Points:…
Videos
Elranatamab (ELRA), a humanized B-cell maturation antigen (BCMA)-CD3 bispecific antibody, has demonstrated efficacy and manageable safety in patients with relapsed or refractory multiple myeloma (RRMM). The MagnetisMM-32 study, a phase 3, open-label, multicenter, randomized trial, aims to compare…
News Article
In a U.S. Food and Drug Administration (FDA) press release on July 30, 2024, the FDA announced its approval of "daratumumab and hyaluronidase-fihj (Darzalex Faspro, Janssen Research & Development, LLC) in combination with bortezomib, lenalidomide, and dexamethasone for induction and…
News Article
At the end of every month, the International Myeloma Foundation Newsroom will feature a wrap-up of some of the most fascinating studies about multiple myeloma from medical journals. Here is the July 2024 edition.
The IMF team of medical editors has provided overviews of key studies. Yet, we…
Event
As we celebrate the 25th anniversary of the Support Group Leaders Summit, we honor the profound impact of support. Each year, patients and care partners gather to share their stories, experiences, and knowledge. It is through the tireless dedication of our support group leaders that we’ve been…
News Article
“We’ve all been there and being part of the myeloma community allows us to share with others who are on a similar journey. Together, we are stronger.” – Jack Aiello
The International Myeloma Foundation honors Jack Aiello and his legacy of service to the myeloma community…
News Article
The International Myeloma Foundation Mourns the Passing of IMF Board Member and Support Group Leader Jack Aiello
STUDIO CITY, CA, July 16, 2024 — Today, the International Myeloma Foundation (IMF) announced with great sadness, the passing of one of the IMF’s Board Members,…
MagnetisMM-30, a Phase 1b Study of ELRA and IBER Combination in Relapsed Refractory Multiple Myeloma
Videos
Abstract Title:
MagnetisMM-30: Aphase1b,open-label study of elranatamab in combination with iberdomide in patients with relapsed or refractory multiple myeloma (RRMM)
Summary:
Dr. Alexander Lesokhin outlines a phase 1b clinical study called MagnetisMM-30,…
Videos
Abstract Title:
DREAMM-7 update: Subgroup analyses from a phase 3 trial of belantamab mafodotin (belamaf) + bortezomib and dexamethasone (BVd) vs daratumumab, bortezomib, and dexamethasone (DVd) in relapsed/refractory multiple myeloma (RRMM)
Summary:
In…
Audio
An Interview with Myeloma Patient and Care Partner Jason and Chad
Their insights on dealing with a multiple myeloma diagnosis as a patient and care partner team
In this episode of "A Day in the Life," Jason Hendler and Chad Billmyer, a patient and care partner married couple, share…
Videos
Captured at the 15th Annual IMWG Summit
This video offers a glimpse into the International Myeloma Foundation's International Myeloma Working Group (IMWG), a collaboration of leading myeloma researchers and clinicians from around the world.
The IMWG plays a critical role in:
…
Videos
Stored and Harvested Stem Cells After CAR T-cell Therapy
In this week's Ask Dr. Durie, IMF Chief Scientific Officer and multiple myeloma expert Dr. Brian G.M. Durie addresses the question of whether stored and harvested stem cells can be utilized to enhance blood counts, especially following CAR…
Videos
Effects of Being Overweight on Risk of Multiple Myeloma
In this week's Ask Dr. Durie, IMF Chief Scientific Officer and multiple myeloma expert Dr. Brian G.M. Durie addresses a patient's concern about the association between obesity and the risk of myeloma.
Dr. Durie discusses…